Sun Pharmaceutical Industries: Strong Q1 Beat on All Fronts but Upside Capped

134 Views02 Aug 2021 10:12
Broker
In the US, Sun diversifying into specialty products like Ilumya, Levulan, BromSite, Cequa, Xelpros, Odomzo, Yonsa, winlwvi etc. Key Risk: (i) Price erosion impact...
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 1-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
ICICI Securities Limited
External broker reports(aggregated public sources)
ICICI Securities Ltd
IndiaEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x